Skip to main content

983 (Lamotrigine Extended-Release 250 mg)

Pill with imprint 983 is Purple, Elliptical / Oval and has been identified as Lamotrigine Extended-Release 250 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc..

Lamotrigine is used in the treatment of bipolar disorder; schizoaffective disorder; epilepsy; seizure prevention and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy. Lamotrigine 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 983

Lamotrigine extended-release 250 mg 983

Lamotrigine Extended-Release

Imprint
983
Strength
250 mg
Color
Purple
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Triazine anticonvulsants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Zydus Pharmaceuticals (USA) Inc.
Manufacturer
Cadila Healthcare Limited
National Drug Code (NDC)
70771-1518

Get help with Imprint Code FAQs.

Related Images for "983"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.